Barry E. Greene
2021 - Sage Therapeutics
In 2021, Barry E. Greene earned a total compensation of $58.9M as Chief Executive Officer and President at Sage Therapeutics, a 7,026% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $501,638 |
|---|---|
| Option Awards | $57,615,277 |
| Salary | $735,000 |
| Other | $12,235 |
| Total | $58,864,150 |
Greene received $57.6M in option awards, accounting for 98% of the total pay in 2021.
Greene also received $501.6K in non-equity incentive plan, $735K in salary and $12.2K in other compensation.
Rankings
In 2021, Barry E. Greene's compensation ranked 62nd out of 12,405 executives tracked by ExecPay. In other words, Greene earned more than 99.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 62 out of 12,405 | 100th |
Division Manufacturing | 19 out of 5,494 | 100th |
Major group Chemicals And Allied Products | 6 out of 2,369 | 100th |
Industry group Drugs | 4 out of 2,090 | 100th |
Industry Pharmaceutical Preparations | 1 out of 1,537 | 100th |
Pay ratio
| Barry E. Greene's Pay | $58,864,150 |
|---|---|
| Median Employee's Pay | $308,210 |
| Pay Ratio | 191to 1 |
In 2021, the annual total compensation of Barry E. Greene was $58,864,150.
The annual total compensation of the median employee at Sage Therapeutics was $308,210.
The ratio of Barry E. Greene's pay to the pay of median employee was therefore 191 to one.
Source: SEC filing on April 28, 2022.
Greene's colleagues
We found four more compensation records of executives who worked with Barry E. Greene at Sage Therapeutics in 2021.